Recordati Group

This study tests a drug called pasireotide to help people who have dangerously low blood sugar after weight-loss surgery. About 93 adults will receive either the drug or a placebo for 12 weeks, then everyone can get the drug for another 36 weeks. The goal is to see if pasireotide…

This study follows 206 adults with Cushing's syndrome who are taking osilodrostat to see how safe and effective the drug is over time. Researchers will track side effects and how well the medicine controls hormone levels. The study does not give any new treatment—it simply observ…

This study is a global registry that collects information from about 429 adults with Cold Agglutinin Disease (CAD) or Cold Agglutinin Syndrome (CAS). It does not test any new treatment but instead observes how the disease behaves, what treatments people receive, and how their sym…